Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-11-05

Clinical Trial Update: E3810-A001-312: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating 10 mg rabeprazole for heartburn in frequent sufferers has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rabeprazole (rabeprazole)

Snippet

Sponsor: Eisai Inc. | Conditions: Heartburn | Phase 3 | Status: COMPLETED | Results posted: 2009-11-05